105
Views
1
CrossRef citations to date
0
Altmetric
Articles

Targeted Screening and Improvement of the Medicinal Properties of Oregano and Rhodiola with Chitosan Oligosaccharide and Vitamin C Using in Vitro Assays for Hyperglycemia and Hypertension Linked to Type 2 Diabetes

, &
Pages 347-362 | Received 02 Dec 2016, Published online: 11 Jul 2017

References

  • Abdullah, N., J. Attia, C. Oldmeadow, R. J. Scott, and E. G. Holliday. 2014. The architecture of risk for type-2 diabetes: Understanding Asia in the context of global findings. Int. J. Endocrinol. 2014:1–21.
  • ACCORD Study Group. 2010. Effects of intensive blood-pressure control in type-2 diabetes mellitus. N. Engl. J. Med. 362:1575–1585.
  • Ademiluyi, A. O., and G. Oboh. 2013. Soybean phenolic-rich extracts inhibit key-enzymes linked to type-2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp. Toxicol. Pathol. 65:305–309.
  • Apostolidis, E. M. S., Y. I. Kwon, and K. Shetty. 2006. Potential of cranberry-based herbal synergies for diabetes and hypertension management. Asia Pac. J. Clin. Nutr. 15:433–441.
  • Assiri, A. M., K. Elbanna, A. Al-Thubiani, and M. F. Ramadan. 2016. Cold-pressed oregano (Origanum vulgare) oil: A rich source of bioactive lipids with novel antioxidant and antimicrobial properties. Eur. Food Res. Technol. 242:1013–1023.
  • Bower, A., S. Marquez, and E. G. De Mejia. 2016. The health benefits of selected culinary herbs and spices found in the traditional Mediterranean diet: Health benefits of culinary herbs and spices. Crit. Rev. Food Sci. 56:2728–2746.
  • Chang, C. L., Y. Lin, A. P. Bartolome, Y. C. Chen, S. C. Chiu, and W. C. Yang. 2013. Herbal therapies for type-2 diabetes mellitus: Chemistry, biology, and potential application of selected plants and compounds. J. Evid.-Based Complement. Altern. Med. 2013:1–33.
  • Chun, S. S., D. A. Vattem, Y. T. Lin, and K. Shetty. 2005. Phenolic antioxidants from clonal oregano (Origanum vulgare) with antimicrobial activity against Helicobacter pylori. Process Biochem. 40:809–816.
  • Cushman, D. W., and H. S. Cheung. 1971. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20:1637–1648.
  • Davie, S. J., B. J. Gould, and J. S. Yudkin. 1992. Effect of vitamin C on glycosylation of proteins. Diabetes 41:167–173.
  • Duncan, A. C., A. K. Jäger, and J. van Staden. 1999. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J. Ethnopharmacol. 68:63–70.
  • Fortmann, S. P., B. U. Burda, C. A. Senger, J. S. Lin, and E. P. Whitlock. 2013. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the US Preventive Services Task Force. Ann. Intern. Med. 159:824–834.
  • Gokce, N., J. F. Keaney, B. Frei, M. Holbrook, M. Olesiak, et al. 1999. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99:3234–3240.
  • Hanhineva, K., R. Törrönen, I. Bondia-Pons, J. Pekkinen, M. Kolehmainen, et al. 2010. Impact of dietary polyphenols on carbohydrate metabolism. Int. J. Mol. Sci. 11:1365–1402.
  • Hermida, R. C., D. E. Ayala, J. R. Fernández, F. Portaluppi, F. Fabbian, and M. H. Smolensky. 2011. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
  • Hernández-Ledesma, B., P. J. Martín-Álvarez, and E. Pueyo. 2003. Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity: Influence of the inhibition type. J. Agric. Food Chem. 51:4175–4179.
  • Hong, S. P., M. H. Kim, S. W. Oh, C. K. Han, and Y. H. Kim. 1998. ACE inhibitory and antihypertensive effect of chitosan oligosaccharides in SHR. Korean J. Food Sci. Technol. 30:1476–1479.
  • Huang, M., C. W. Fong, E. Khor, and L. Y. Lim. 2005. Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation. J. Controlled Release 106:391–406.
  • Kelly, G. S. 2001. Rhodiola rosea: A possible plant adaptogen. Altern. Med. Rev. 6:293–302.
  • Kim, Y. J. 2007. Antimelanogenic and antioxidant properties of gallic acid. Biol. Pharm. Bull. 30:1052–1055.
  • Knekt, P., A. Reunanen, R. Jävinen, R. Seppänen, M. Heliövaara, and A. Aromaa. 1994. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139:1180–1189.
  • Kwon, Y. I., D. A. Vattem, and K. Shetty. 2006a. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac. J. Clin. Nutr. 15:107–118.
  • Kwon, Y.I., E. Apostolidis, and K. Shetty. 2006b. Anti-diabetes functionality of Kefir culture-mediated fermented soymilk supplemented with rhodiola extracts. Food Biotechnol. 20:13–29.
  • Lacaille-Dubois, M. A., U. Franck, and H. Wagner. 2001. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 8:47–52.
  • Lam, D. W., and D. LeRoith. 2012. The worldwide diabetes epidemic. Curr. Opin. Endocrinol. Diabetes Obes. 19:93–96.
  • McCue, P. P., and K. Shetty. 2004. Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nutr. 13:101–106.
  • Muzzarelli, R. A., J. Boudrant, D. Meyer, N. Manno, M. DeMarchis, and M. G. Paoletti. 2012. Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science, on the chitin bicentennial. Carbohydr. Polym. 87:995–1012.
  • Nakamura, Y., Y. Ohto, A. Murakami, and H. Ohigashi. 1998. Superoxide scavenging activity of rosmarinic acid from Perilla frutescens Britton var. acuta f. viridis. J. Agric. Food Chem. 46:4545–4550.
  • Niaz, T., S. Shabbir, S. Manzoor, A. Rehman, A. Rahman, et al. 2016. Antihypertensive nano-ceuticales based on chitosan biopolymer: Physico-chemical evaluation and release kinetics. Carbohydr. Polym. 142:268–274.
  • Pereira, D. F., L. H. Cazarolli, C. Lavado, V. Mengatto, M. S. R. B. Figueiredo, et al 2011. Effects of flavonoids on α-glucosidase activity: Potential targets for glucose homeostasis. Nutrition 27:1161–1167.
  • Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1450–1456.
  • Sarkar, D., and K. Shetty. 2014. Metabolic stimulation of plant phenolics for food preservation and health. Annu. Rev. Food Sci. Technol. 5:395–413.
  • Sarkar, D., C. Ankolekar, M. Pinto, and K. Shetty. 2015. Dietary functional benefits of Bartlett and Starkrimson pears for potential management of hyperglycemia, hypertension and ulcer bacteria Helicobacter pylori while supporting beneficial probiotic bacterial response. Food Res. Int. 69:80–90.
  • Saunders, D., D. Poppleton, A. Struchkov, and R. Ireland. 2014. Analysis of five bioactive compounds from naturally occurring Rhodiola rosea in eastern Canada. Can J. Plant Sci. 94:741–748.
  • Sharifi, N., E. Souri, S. A. Ziai, G. Amin, and M. Amanlou. 2013. Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay. DARU 21:1.
  • Shetty, K., O. F. Curtis, R. E. Levin, R. Witkowsky, and W. Ang. 1995. Prevention of vitrification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J. Plant Physiol. 147:447–451.
  • Shouk, R., A. Abdou, K. Shetty, D. Sarkar, and A. H. Eid. 2014. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutr. Res. 34:106–115.
  • Sohi, K. K., N. Mittal, M. K. Hundal, and K. L. Khanduja. 2003. Gallic acid, an antioxidant, exhibits antiapoptotic potential in normal human lymphocytes: A Bcl-2 independent mechanism. J. Nutr. Sci. Vitaminol. 49:221–227.
  • Thu, O. K., O. Spigset, O. G. Nilsen, and B. Hellum. 2016. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur. J. Clin. Pharmacol. 72:295–300.
  • van Dam, R. M., N. Naidoo, and R. Landberg. 2013. Dietary flavonoids and the development of type-2 diabetes and cardiovascular diseases: Review of recent findings. Curr. Opin. Lipidol. 24:25–33.
  • Wedick, N. M., A. Pan, A. Cassidy, E. B. Rimm, L. Sampson, et al. 2012. Dietary flavonoid intakes and risk of type-2 diabetes in US men and women. Am. J. Clin. Nutr. ajcn-028894.
  • World Health Organization. 2016. Diabetes Fact Sheet. http://www.who.int/mediacentre/factsheets/fs312/en, accessed 29 September 2016.
  • Yen, G. C., P. D. Duh, and H. L. Tsai. 2002. Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem. 79:307–313.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.